等待開盤 11-05 09:30:00 美东时间
-0.820
-0.60%
今日重点评级关注:瑞银:维持Syndax Pharmaceuticals"买入"评级,目标价从35美元升至38美元;HC Wainwright & Co.:维持Benitec Biopharma"买入"评级,目标价从28美元升至35美元
今天 10:35
Needham analyst Ami Fadia reiterates Axsome Therapeutics (NASDAQ:AXSM) with a Buy and maintains $154 price target.
11-04 17:23
Axsome Therapeutics shares are trading lower. The company reported Q3 financial...
11-03 21:43
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
11-03 19:11
Axsome Therapeutics (NASDAQ:AXSM) is set to give its latest quarterly earnings ...
11-01 02:01
今日重点评级关注:Maxim Group:维持Rani Therapeutics Hldgs"买入"评级,目标价从5美元升至10美元;韦德布什:维持Corbus Pharmaceuticals"跑赢大市"评级,目标价从31美元升至38美元
10-21 18:13
Morgan Stanley analyst Sean Laaman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Overweight and raises the price target from $191 to $194.
10-20 23:24
Axsome Therapeutics joins Mental Illness Awareness Week (MIAW), partnering with NAMI to promote mental health through community support. The theme "Building Community: Supporting Mental Well-being Together" highlights the importance of connections and local action. Axsome shares NAMI resources, including support groups and initiatives for diverse communities, to address the significant impact of mental health issues in the U.S., where 1 in 5 adul...
10-09 11:00
今日重点评级关注:JMP证券:维持Ocular Therapeutix"跑赢大市"评级,目标价从20美元升至29美元;汇丰银行:上调Banco BBVA Argentina评级至"买入",目标价从21美元下调至17美元
10-02 15:08